Table of contents
Sharing traceability related information between pharmacy workflows to help health-system pharmacies with Drug Supply Chain Security Act (DSCSA) requirements
BOSTON, Mass. — November 12, 2026 — TraceLink, the world's largest Agentic Business Network, today announced a collaboration with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, to enable customers to meet requirements around pharmacy supply chain traceability.
“Hospital pharmacy teams need immediate access to the right information without adding more steps to their already demanding workflows,” said Shabbir Dahod, President and CEO of TraceLink. “By bringing inventory and DSCSA verification into an integrated experience, we’re helping pharmacy staff work more efficiently, increase productivity, and focus more of their time and attention on medication availability and patient care.”
Through this collaboration, BD and TraceLink will work together to share traceability information from TraceLink’s DSCSA solution, US Product Track, into BD Pyxis™ Logistics inventory management to provide an improved workflow experience.
“By connecting traceability information with pharmacy inventory workflows, this collaboration is intended to support a more streamlined approach to managing drug traceability requirements,” said Nick Piper, Director of Innovation Marketing, Dispensing, BD Medication Management Solutions (MMS).
Learn more about TraceLink's DSCSA compliance solutions for hospitals and health systems.
